Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
947,4 INR | -0,40% | +2,74% | +37,46% |
26/04 | Zwakke kwartaalcijfers wegen vrijdag op Indiase aandelen | MT |
26/04 | Zydus Lifesciences krijgt definitieve goedkeuring van de Amerikaanse FDA voor generieke acnecrème | MT |
Vakgebied
Aantal werknemers: 23 026
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals
87,0
%
| 132 864 | 87,0 % | 149 926 | 87,0 % | +12,84% |
Consumer Products
13,0
%
| 19 788 | 13,0 % | 22 448 | 13,0 % | +13,44% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
India
44,3
%
| 72 532 | 47,5 % | 76 399 | 44,3 % | +5,33% |
United States
43,4
%
| 59 487 | 39,0 % | 74 868 | 43,4 % | +25,86% |
Others
12,2
%
| 20 633 | 13,5 % | 21 107 | 12,2 % | +2,30% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 44 | 01-08-97 | |
Director of Finance/CFO | - | - | |
Chairman | 71 | 15-05-95 | |
Compliance Officer | - | 07-02-19 | |
Director/Board Member | 68 | 01-01-77 | |
Arvind Bothra
IRC | Investor Relations Contact | - | - |
Mathew George
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 72 | 06-12-18 | |
Chairman | 71 | 15-05-95 | |
Director/Board Member | 69 | 01-08-97 | |
Chief Executive Officer | 44 | 01-08-97 | |
Director/Board Member | 55 | 16-08-03 | |
Director/Board Member | 68 | 01-01-77 | |
Akhil Monappa
BRD | Director/Board Member | 44 | 29-11-22 |
Director/Board Member | 81 | 06-05-11 | |
Director/Board Member | 68 | 16-05-14 | |
Director/Board Member | 37 | 29-11-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 006 233 990 | 250 227 197 ( 24,87 %) | 0 | 24,87 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ZYDUS WELLNESS LIMITED 57.59% | 36 647 509 | 57.59% | 646 321 332 $ |
Bedrijfsgegevens
Zydus Lifesciences Ltd.
Zydus Corporate Park Scheme No. 63, Survey No. 536
382481, Ahmedabad
+91 79 7180 0000
http://www.zyduscadila.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Food: Major Diversified
| |
Zydus Pharmaceuticals Ltd.
Zydus Pharmaceuticals Ltd. Medical DistributorsDistribution Services Zydus Pharmaceuticals Ltd. distributes pharmaceuticals and cosmetics products. The company is headquartered in Ahmedabad, India. |
Medical Distributors
|
Alidac Pharmaceuticals Ltd.
Alidac Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Zydus Lifesciences Ltd., Alidac Pharmaceuticals Ltd. is an Indian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Matoda, India. |
Pharmaceuticals: Major
|
Zydus Wellness Products Ltd.
Zydus Wellness Products Ltd. Pharmaceuticals: OtherHealth Technology Zydus Wellness Products Ltd. is an Indian company that manufactures health and wellness products. |
Pharmaceuticals: Other
|
Zydus Vtec Ltd.
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,46% | 11,43 mld. | |
+19,62% | 43,34 mld. | |
+20,44% | 21,96 mld. | |
+10,86% | 14,09 mld. | |
+13,07% | 13,64 mld. | |
-8,59% | 6,86 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+8,46% | 5,22 mld. | |
-4,29% | 4,71 mld. |
- Beurs
- Aandelen
- Koers ZYDUSLIFE
- Onderneming Zydus Lifesciences Limited